• (000) 123 458 789
  • office@worldpatientsalliance.org
Home Events Webinar Equity and Access in Healthcare
Healthcare without barriers: Fair access for every patient.
Webinar Equity and Access in Healthcare

Webinar Equity and Access in Healthcare
Healthcare without barriers: Fair access for every patient.

Date: 25 May 2026
Organized by: World Patients Alliance (WPA)

Overview

The World Patients Alliance Asia Pacific Region organized the webinar “Equity and Access in Healthcare” on 26 May 2026 under the theme “Healthcare without barriers: Fair access for every patient.” The session focused on the barriers that continue to limit timely, affordable, culturally appropriate, and quality healthcare for patients across different regions.

The discussion placed patient experience at the centre of the equity agenda. It recognized that access is not limited to the presence of healthcare services. Access also depends on affordability, distance, information, trust, continuity of care, timely diagnosis, availability of medicines and diagnostics, and whether health systems are designed with patient input.

The webinar brought together WPA leadership, public health and community-engagement expert, patient advocates, and healthcare leaders. Speakers discussed how patients and patient organizations can help identify barriers, generate evidence, support peer networks, engage communities, and work with health authorities to strengthen fairness and accountability in healthcare delivery.

Objectives of the Webinar

Highlight the main equity and access challenges experienced by patients, with attention to the Asia Pacific region and wider global relevance.

Explain the difference between equality and equity, and why equitable healthcare requires support based on patient needs and circumstances.

Identify practical barriers to care, including cost, distance, language, system complexity, lack of information, shortage of specialists, and limited trust.

Show how patient organizations identify barriers, collect patient insights, provide peer support, and generate evidence for service and policy improvement.

Present examples of patient-led action that can strengthen access, accountability, timely diagnosis, and continuity of care.

Encourage patient groups to advance equitable access through advocacy, community engagement, collaboration, and practical system-level dialogue.

Agenda

Welcome and Opening Remarks

Andrew Spiegel | Chair, Board of Directors | WPA

Equity and Access in Healthcare, an Overview

Dr. Karriem Watson | Research Associate Professor University of Illinois

Panel Discussion

Moderator:

Edmund Lau I WPA Advisory Board Member

Panelists:

Sangeeta Wadhwa | President, Youth Thalassemia Alliance (YTA)

Nidhi Swarup I Chair, Alliance of Patients’ Organizations Singapore (APOS)

Mohammed A. Omair I Professor at King Saud University, Saudi Arabia

Dr. Karriem Watson | Research Associate Professor University of Illinois

Closing Remarks

Hussain Jafri | CEO | WPA

Welcome and Opening Remarks

Andrew Spiegel, Chair of the WPA Board of Directors, opened the webinar by welcoming participants and placing the discussion within WPA’s broader commitment to patient centered healthcare. He emphasized that a person’s access to care should not be determined by where they live, their socioeconomic position, or the capacity of the local health system around them.

Drawing on experience from the cancer field, he noted that geography can have a direct effect on access to diagnostics, treatment, support services, and outcomes. His remarks set the tone for the webinar by framing equity and access as patient-safety, quality-of-care, and rights-based concerns.

He also highlighted the importance of inclusive participation in global patient dialogue. In this context, the use of multilingual tool (Wordly) by WPA was highlighted as a practical step to support broader accessibility for participants across regions.

Key Presentation

Setting the Context: Equity and Access in Healthcare

Dr. Karriem Watson delivered the overview presentation on equity and access in healthcare. He clarified the distinction between equality and equity. Equality means offering the same resources or support to everyone. Equity requires a deeper understanding of people’s different circumstances and the removal of barriers that prevent them from receiving appropriate care.

He explained that healthcare access is shaped by many factors beyond the availability of hospitals or clinics. These include transportation, cost, language, culture, health literacy, system complexity, and trust. He also noted that access includes the ability to receive information, participate in research, and benefit from health systems that are relevant to local communities.

A central message of the presentation was that health systems often design services for patients, but not with patients. This can result in services that do not reflect lived experience, daily realities, or the practical barriers faced by underserved populations. Dr. Watson stressed that patient engagement should begin early and should inform research, service design, outreach, and care delivery.

The presentation also addressed trust. Dr. Watson emphasized that trust should not be demanded from patients. It must be earned by building trustworthy systems. This requires listening to communities, ensuring representation, recognizing past and current barriers, and creating spaces where patient voices are taken seriously.

He further highlighted the value of community-engaged care and research. Bringing services closer to patients, working with community organizations, and meeting people where they are can help reduce barriers and improve participation. These approaches are especially important for communities that have historically been excluded from care, research, or decision-making.

Key Insights from the Presentation

Equity is different from equality. It requires tailored support based on patient needs and circumstances.

Access includes services, information, education, diagnostics, medicines, research participation, and continuity of care.

Underserved communities are often excluded because systems do not actively reach or involve them.

Trust is built through trustworthy systems, patient listening, community engagement, and representation.

Healthcare systems should be designed with patients, not only for patients.

Community partnerships can help bring care, information, and support closer to the people who need them.

Panel Discussion

The panel discussion, moderated by Edmund Lau, explored how access barriers affect different patient communities and health conditions. The discussion connected broad equity principles with practical experiences from thalassemia, chronic diseases, inflammatory bowel disease, autoimmune and rheumatic conditions, and underserved communities.

Access, Location, and Trust

Dr. Karriem Watson emphasized that physical access remains one of the most visible barriers to healthcare. Specialized services are often located far from the communities that need them most. This creates long and difficult journeys for patients, especially for those in rural or underserved areas.

He also highlighted delays caused by shortages of specialists and uneven distribution of services. These gaps can affect early diagnosis, timely treatment, and long-term care. Dr. Watson suggested that health systems should consider approaches that bring care closer to communities, including satellite clinics, community-based services, and home visits where feasible.

He returned to the issue of trust and stressed that patients are more likely to engage with health systems when they feel heard, respected, and included. Shared decision-making was presented as an important part of this process. Patients should be supported to understand their options and take part in decisions that affect their care.

Access Challenges for People Living with Thalassemia

Sangeeta Wadhwa highlighted the major access challenges faced by people living with thalassemia, particularly in resource-constrained settings. She explained that regular access to safe blood remains a serious concern. Shortages of blood and limited awareness about voluntary blood donation can disrupt essential transfusion care.

She also raised concerns about the availability and safety of screened blood. Inadequate screening for infections can place patients at serious risk. She further noted that access to essential medicines, including iron chelation therapy, remains difficult for many patients, especially when public health systems are unable to ensure regular supply.

Her contribution showed that access is not a single issue. For patients with thalassemia, it includes blood safety, medicine availability, screening, diagnosis, affordability, specialist care, and long-term follow-up. Gaps in any of these areas can affect survival, quality of life, and continuity of care.

Chronic Conditions, Research Gaps, and Peer Support

Nidhi Swarup discussed the barriers faced by people living with chronic conditions, with particular attention to gaps in research, diagnosis, and long-term care. She noted that many studies and clinical trials are concentrated in Western settings. This can limit the relevance of evidence for Asian populations and other underrepresented communities.

She explained that some conditions may present differently across populations. When regional evidence is limited, symptoms may be missed or misunderstood, which can delay diagnosis and lead to inappropriate management. She used chronic conditions, including Crohn’s disease, to illustrate how health systems may not fully recognize the lived experience of patients in different contexts.

She also emphasized that healthcare systems often focus on visible or measurable symptoms while overlooking pain, fatigue, mental health concerns, and quality-of-life issues. These concerns may be difficult to measure, but they are central to the patient experience.

Nidhi also stressed the role of patient organizations and peer support networks. These groups help patients navigate care, understand their condition, access practical information, and receive emotional support. Her remarks reinforced the need to formally recognize patient organizations as important partners in health systems.

Delayed Diagnosis and Specialist Access in Rheumatic Diseases

Dr. Mohammed A. Omair highlighted the challenges faced by patients with autoimmune and rheumatic diseases. He explained that many of these conditions begin with mild or non-specific symptoms, such as pain or fatigue. As a result, patients may live for years without a clear diagnosis.

He noted that limited awareness among patients and primary healthcare providers can contribute to delays. Patients may also be uncertain about which specialist to consult. At the same time, shortages and uneven distribution of rheumatologists mean that access to specialized care is often shaped by geography.

Dr. Omair explained that many rheumatic diseases do not have simple screening tools. Diagnosis may require clinical assessment, imaging, and laboratory investigations. These requirements can create additional access challenges, especially in areas where specialist services are limited.

He also referred to conditions such as ankylosing spondylitis and fibromyalgia to show how symptoms can be misunderstood or overlooked. His remarks underlined the importance of awareness, timely referral, appropriate support services, and patient-centred disease management.

Q&A Session

The Q&A session brought together several cross-cutting concerns. One issue was long waiting times, which affect patients in both low-resource and high-income settings. Speakers noted that waiting times are often linked to system capacity, referral pathways, triaging, and shortages of health professionals.

The discussion also addressed the need for better patient guidance. Low awareness can lead patients to delay care, seek care at the wrong point in the system, or use emergency services when earlier support may have been more appropriate. Clear information and navigation support were identified as important elements of access.

Participants also discussed the role of technology, including tele-support and AI, as possible tools to improve efficiency and patient guidance. The discussion recognized that technology can support access, but it should be used carefully and in ways that remain inclusive, patient-centred, and responsive to local realities.

Another issue raised was stigma, particularly for visible, chronic, or poorly understood conditions. Speakers emphasized the importance of culturally sensitive care, inclusive training, and better representation of diverse patient experiences in healthcare systems.

Key Takeaways

Equity requires health systems to identify and remove barriers that affect different patients in different ways.

Access must be understood broadly. It includes affordability, distance, information, diagnostics, medicines, specialist care, trust, research participation, and continuity of care.

Health systems should be designed with patients and patient organizations from the beginning, not only after services are already developed.

Patient organizations provide practical support, peer connection, community insight, and evidence that can inform better policy and service design.

Trust is a core requirement for equitable healthcare. It is built through respectful engagement, representation, listening, and reliable systems.

Delayed diagnosis remains a major access issue across chronic, rare, autoimmune, and complex conditions.

Technology can support access and patient guidance, but it should not replace inclusive, human-centred care.

Fair access requires collaboration between patients, patient organizations, healthcare professionals, researchers, health authorities, and policymakers.

Closing Remarks

Dr. Hussain Jafri, CEO of the World Patients Alliance, closed the webinar by emphasizing that healthcare access is broader than service availability. It also includes affordability, trust, continuity, timely diagnosis, and the ability of patients to participate meaningfully in decisions that affect their care.

He reiterated that patients must be recognized as active partners in shaping health systems and policies. He highlighted that barriers such as cost, distance, lack of information, and system complexity must be addressed if healthcare systems are to become more equitable and responsive.

Dr. Jafri reaffirmed WPA’s commitment to promoting patient-centred approaches, strengthening patient voice, and supporting global collaboration on fair access to quality healthcare.

Conclusion

The webinar highlighted that equity and access are central to safe, fair, and people-centred healthcare. The discussion showed that barriers to care are often interconnected. Cost, geography, diagnosis delays, shortage of specialists, limited awareness, lack of trust, poor representation in research, and weak continuity of care can all affect whether patients receive the care they need.

The session also emphasized that patient organizations are essential partners in addressing these barriers. They help identify real patient needs, support communities, strengthen awareness, collect lived-experience evidence, and engage with health authorities on practical improvements.

For WPA, the webinar reinforced the importance of keeping patient voices at the centre of equity and access discussions. Meaningful progress depends on health systems that listen to patients, work with communities, and treat access as a shared responsibility across policy, service delivery, research, and advocacy.

Karriem S. Watson
Karriem S. Watson, DHSc, MS, MPH
Chief Executive Officer, UI Health Mile Square Health Center Dr. Karriem S. Watson, DHSc, MS, MPH is the Chief Executive Officer for UI Health Mile Square Health Center. As part of the University of Illinois Hospital and Health Science System, Mile Square Health Center includes Federally Qualified Health Centers throughout south and west Chicago, Cicero and Rockford communities, with a mission to provide holistic, quality health services amid an underserved, urban community. The system includes primary care, behavioral health, dental services, as well as school-based health centers. Prior to joining the Mile Square, Dr. Watson was the Chief Engagement Officer for the National Institutes of Health’s (NIH) All of Us Research Program, where he led the All of Us Research Program’s efforts to foster relationships with participants, communities, researchers and providers across the United States and territories through equitable engagement to build one of the largest, most diverse health datasets to advance precision medicine research. Dr. Watson has spent over 15 years conducting cancer disparities research. He completed his post-doctoral training in cancer center leadership under Dr. Robert A. Winn at the University of Illinois Cancer Center and went on to become an independent funded researcher with funding from the NIH’s NCI, NIMHD and NHLBI, along with industry and foundational sponsors. Dr. Watson’s work spans across community engaged research, community based participatory research (CBPR), and implementation and dissemination science, and global health. Dr. Watson’s work has examined cancer prevention and control interventions in Cuba, Ethiopia, Uganda, and Israel. He has also studied the impact of community health workers (CHWs) in rural Haiti and faith based settings in the US. His work with Citizen Scientists has engaged barbers, faith-based leaders, fraternity members and other civic and community leaders to improve diversity, equity, and inclusion in clinical trials. Dr. Watson is also committed to engaging the next generation of clinical research scholars and public health leaders. He is a Research Associate Professor at the UIC School of Public Health and has served on the board of It Takes a Village of Schools and has been recognized as an Innovator in STEM by the Chicago Urban League. His community service has been further demonstrated by his roles as former board chair of Community Campus Partnerships for Health (CCPH) and his board roles for Susan G. Komen Chicago and countless others. Dr. Watson is a native of Muskegon Heights, Michigan, and completed his undergraduate training in Biology at the University of Michigan, his graduate work in Basic Medical Research at Wayne State University School of Medicine, his graduate MPH training in Community Health Sciences at UIC School of Public Health and his doctorate training in global health at Nova Southeastern University. He completed postdoctoral training in cancer center leadership under Dr. Robert A. Winn at the University of Illinois Cancer Center. He is a proud member of Alpha Phi Alpha Fraternity, Inc., and has served the faith communities of the Apostolic Faith Church under the leadership of Bishop Horace E. Smith, MD and University Church under the leadership of Pastor Julian DeShazier.
Edmund Lau
Edmund Lau is a patient advocate and educator based in Singapore. He serves on the Advisory Board of the World Patients Alliance and is an Ambassador for the International Federation of Psoriasis Associations. Edmund serves as Co-Chair of the GlobalSkin Asia Pacific Working Group, supporting collaboration and capacity-building across more than 30 countries in the region to advance patient-centred dermatology care, equity, and access. Edmund is a trained EUPATI Fellow. He is also a co-author of patient-centred work in psoriasis, contributing to efforts that strengthen value-based care and outcomes that matter to people living with psoriatic disease. He is also the General Secretary of the Psoriasis Association of Singapore, supporting local and international efforts to strengthen patient engagement, improve access to care, and advance health policy dialogue. Alongside his advocacy work, Edmund is an associate lecturer with more than 25 years of teaching experience across universities in the United States, Australia, and the United Kingdom. He holds a Master of Health Economics, Management and Policy (University of Newcastle), a Master of Facilities and Environment Management (University College London), an MBA (International Business) (Oklahoma City University), a Master of Environmental Science (Singapore University of Social Sciences), and he is currently pursuing further postgraduate studies in public health and international law.
Nidhi Swarup
Nidhi Swarup is an internationally recognized patient advocacy leader with extensive experience across healthcare, social services, and nonprofit development. Despite living with multiple chronic conditions, she has successfully facilitated the formation of patient support groups across Asia and contributed significantly to advancing patient engagement on local, regional, and global platforms. Her strengths include strategic planning, organizational leadership, public communication, and the ability to conceptualize and implement impactful initiatives focused on holistic patient care. Academically trained in operations research, finance, and professional counselling, Nidhi currently serves on numerous influential committees and advisory boards, including the WHO Patients for Patient Safety Network, major health ministries, academic institutions, and international pharmaceutical panels. She also leads key patient organizations in Singapore. Her work includes published research on inflammatory bowel disease, patient engagement, and healthcare systems, along with conference contributions that highlight her commitment to improving patient experiences and outcomes worldwide.
Sangeeta H. Wadhwa
Sangeeta H. Wadhwa
Sangeeta H. Wadhwa is a psychologist, counselor, motivational speaker, healthcare administrator, and clinical nutritionist with over 25 years of experience. As a lifelong thalassemia warrior, she has dedicated her career to advancing mental health support, thalassemia awareness, and patient advocacy across India. Her work spans psychological counseling, adolescent guidance, healthcare outreach, and large-scale awareness initiatives. She is a founder member of the Youth Thalassemia Alliance (YTA) and actively collaborates with multiple national and international health organizations to promote early screening, prevention, and holistic patient care. Throughout her career, she has led numerous national conferences, blood donation drives, workshops, and public education campaigns. Sangeeta has been recognized with multiple awards for her contribution to thalassemia awareness and has been featured in major media outlets like Hindustan Times, Times of India, CNBC, and various health podcasts. Her strengths include strong communication, leadership, empathy, and resilience, and she extends her social impact through activities like travel blogging, stand up comedy, marathon participation, and skill building classes for underprivileged communities.
Dr. Mohammed A. Omair
Mohammed A. Omair
Rheumatologist and Professor, King Saud University Founding President, Rheumatism and Fibromyalgia Association Dr. Mohammed A. Omair is a distinguished Consultant Rheumatologist and academic leader based in Riyadh, Saudi Arabia. He serves in the Division of Rheumatology at King Saud University, where he is actively engaged in clinical practice, teaching, and research. Dr. Omair completed his medical education at King Saud University and pursued advanced training in internal medicine and rheumatology through the Saudi Board, along with international fellowships focusing on rheumatoid arthritis and systemic sclerosis. His clinical expertise includes autoimmune and inflammatory rheumatic diseases, with a strong emphasis on patient-centered care and effective disease management. In his academic role, Dr. Omair has played a key part in advancing rheumatology education and services. He established the Rheumatology Fellowship Program at King Saud University and has contributed to the development of specialized clinics in the field. He is also deeply committed to mentoring medical students, residents, and specialists. An active researcher, Dr. Omair has authored over 20 peer-reviewed publications in international journals. His work focuses on rheumatic diseases, treatment outcomes, and patient behavior, and he has contributed to both regional and global clinical guidelines. His research collaborations and academic contributions have earned him strong recognition within the field. Beyond his academic and clinical responsibilities, Dr. Omair is a dedicated advocate for patients. He is the Founder and President of the Charitable Association for Rheumatic Diseases and has led initiatives through rheumatism and fibromyalgia associations. He is widely recognized for promoting healthcare awareness, improving access to care, and supporting better patient outcomes. Dr. Omair is also an active participant in national and international conferences and a member of various professional rheumatology networks.

Date

May 26 2026
Expired!

Time

8:00 am - 6:00 pm

2 Comments

Nenad Mitrovic
26 May, 2026

great webinar, thank you

Nenad Mitrovic
26 May, 2026

how to get a certificate about the attended webinar

Leave A Reply

Your email address will not be published. Required fields are marked *